Literature DB >> 2694714

Hormone-fuel metabolism during exercise of insulin-dependent diabetic patients treated with an artificial B-cell unit.

M C Foss1, L N Cunningham, T T Aoki.   

Abstract

The effects of restoration of glucose homeostasis on hormone-fuel metabolism of diabetic individuals during exercise (40% maximal O2 consumption) were determined by monitoring fuel oxidation rates and levels of substrates and hormones in nine normal subjects and five insulin-dependent diabetic patients while on conventional insulin therapy and after 3 days on artificial B-cell directed glucose regulation. The non-protein respiratory quotient (npRQ) and carbohydrate oxidation rate of the conventionally-treated diabetic subjects (0.908 +/- 0.002 and 538 +/- 5 mg/m2.min) were lower and the lipid oxidation rate (101 +/- 2 mg/m2.min) was significantly higher than those of the normal group during the bicycle exercise (101 +/- 2 mg/m2.min) was significantly 70 +/- 4 mg/m2.min, respectively). After 3 days of artificial B-cell insulin therapy, the npRQ and carbohydrate oxidation rate of the exercising diabetics significantly increased to 0.965 +/- 0.004 and 693 +/- 13 mg/m2.min, while the lipid oxidation rate declined to 39 +/- 4 mg/m2.min (p less than 0.001). We conclude that artificial B-cell directed insulin therapy increases carbohydrate oxidation and decreases lipid oxidation in exercising insulin-dependent diabetic subjects. However, if restoration of metabolic response identical to that of exercising normals is desired, the excess in carbohydrate oxidation coincident with elevated blood lactate and pyruvate levels suggest that the artificial B-cell therapy may not have been completely optimal, probably due to the hyperinsulinization of the diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2694714     DOI: 10.1007/BF02581384

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  17 in total

1.  Respiratory quotient during exercise.

Authors:  B ISSEKUTZ; K RODAHL
Journal:  J Appl Physiol       Date:  1961-07       Impact factor: 3.531

2.  Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose.

Authors:  A S HUGGETT; D A NIXON
Journal:  Lancet       Date:  1957-08-24       Impact factor: 79.321

3.  Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus.

Authors:  J Wahren; L Hagenfeldt; P Felig
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

4.  The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system).

Authors:  E F Pfeiffer; C Thum; A H Clemens
Journal:  Horm Metab Res       Date:  1974-09       Impact factor: 2.936

5.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

6.  Metabolic and hormonal effects of muscular exercise in juvenile type diabetics.

Authors:  M Berger; P Berchtold; H J Cüppers; H Drost; H K Kley; W A Müller; W Wiegelmann; H Zimmerman-Telschow; F A Gries; H L Krüskemper; H Zimmermann
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

7.  Glucose metabolism during leg exercise in man.

Authors:  J Wahren; P Felig; G Ahlborg; L Jorfeldt
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

8.  Physical exercise and fuel homeostasis in diabetes mellitus.

Authors:  J Wahren; P Felig; L Hagenfeldt
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

9.  Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty acids, and amino acids.

Authors:  G Ahlborg; P Felig; L Hagenfeldt; R Hendler; J Wahren
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

10.  Restoration of glucose homeostasis in insulin-dependent diabetic subjects. An inducible process.

Authors:  M C Foss; F V Vlachokosta; L N Cunningham; T T Aoki
Journal:  Diabetes       Date:  1982-01       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.